Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$499K Sell
2,720
-3,360
-55% -$619K 0.02% 525
2025
Q4
$1.07M Sell
6,080
-1,670
-22% -$273K 0.05% 301
2025
Q3
$1.09M Buy
7,750
+830
+12% +$112K 0.05% 301
2025
Q2
$869K Buy
6,920
+3,190
+86% +$397K 0.04% 371
2025
Q1
$510K Buy
+3,730
New +$533K 0.03% 471
2022
Q4
Sell
-6,378
Closed -$1.8M 958
2022
Q3
$1.7M Buy
+6,378
New +$1.35M 0.08% 248
2022
Q1
Sell
-2,800
Closed -$609K 1170
2021
Q4
$672K Buy
+2,800
New +$720K 0.02% 554
2021
Q3
Sell
-1,832
Closed -$600K 1181
2021
Q2
$634K Sell
1,832
-9,289
-84% -$2.81M 0.03% 531
2021
Q1
$3.11M Sell
11,121
-3,968
-26% -$1.07M 0.13% 151
2020
Q4
$3.69M Buy
+15,089
New +$3.89M 0.14% 122
2020
Q3
Sell
-19,196
Closed -$5.35M 794
2020
Q2
$5.14M Buy
19,196
+18,376
+2,241% +$5.52M 0.29% 86
2020
Q1
$259K Buy
+820
New +$249K 0.02% 389

Other funds holding BIIB

CSS LLC's BIIB Position: Q1 2026 in Review

CSS LLC reduced its Biogen (BIIB) stake by 55% in Q1 2026, selling an estimated $619K and leaving 2,720 shares worth $499K. The position accounts for 0.02% of the portfolio, ranked #525.

CSS LLC first reported a position in BIIB in Q1 2020 and has held it in 12 quarters since. The position peaked at $5.14M in Q2 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • CSS LLC held 2,720 shares of Biogen worth $499K as of Q1 2026.
  • CSS LLC sold 3,360 Biogen shares in Q1 2026, an estimated $619K.
  • Biogen made up 0.02% of CSS LLC's portfolio in Q1 2026, its #525 holding.
  • CSS LLC first reported a position in Biogen in Q1 2020 and has held it in 12 quarters since.
  • CSS LLC's Biogen position peaked at $5.14M in Q2 2020.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.